Form 8-K - Current report:
SEC Accession No. 0000950170-25-090172
Filing Date
2025-06-26
Accepted
2025-06-26 07:13:10
Documents
12
Period of Report
2025-06-26
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ivvd-20250626.htm   iXBRL 8-K 58985
2 EX-99.1 ivvd-ex99_1.htm EX-99.1 46855
3 GRAPHIC img59752938_0.jpg GRAPHIC 85687
  Complete submission text file 0000950170-25-090172.txt   352220

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT ivvd-20250626.xsd EX-101.SCH 31866
14 EXTRACTED XBRL INSTANCE DOCUMENT ivvd-20250626_htm.xml XML 4874
Mailing Address 1601 TRAPELO ROAD SUITE 178 WALTHAM MA 02451
Business Address 1601 TRAPELO ROAD SUITE 178 WALTHAM MA 02451 (781) 819-0080
Invivyd, Inc. (Filer) CIK: 0001832038 (see all company filings)

EIN.: 851403134 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40703 | Film No.: 251075049
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)